Search through all our worldwide HIV and AIDS news and features, using the topics below to filter your results by subjects including HIV treatment, transmission and prevention, and hepatitis and TB co-infections.

Kidney problems news


From To
New study will probe safety of HIV-to-HIV kidney transplants

A new study may pave the way for HIV-positive patients to receive organ transplants.The National Institutes of Health this month announced the launch of the HOPE in Action Multicenter Kidney Study to research the safety of kidney transplantation from HIV-positive donors to HIV-positive recipients.

21 May 2018
MD Magazine
NIH Clinical Trial to Track Outcomes of Kidney Transplantation From HIV-Positive Donors to HIV-Positive Recipients

The study will track the clinical outcomes of 160 kidney transplants. All transplant recipients in the study will be living with HIV; 80 of them will receive kidneys from deceased donors who had HIV, and 80 will receive kidneys from HIV-uninfected deceased donors serving as the control group.

08 May 2018
NIAID press release
People With HIV and Kidney Disease Have Major Health Risks

Researchers urge clinicians to closely monitor their patients with HIV and chronic kidney disease.

09 March 2018
Shift in HIV-Associated Kidney Disease Characterized

Successful antiretroviral therapy for human immunodeficiency virus (HIV) infection has altered the spectrum of HIV-associated kidney disease over the past 30 years, according to the authors of a new review published in the New England Journal of Medicine.

15 December 2017
Renal & Urology News
HIV patients at greater risk of both heart and kidney disease

Drawing on data from the international D:A:D (Data collection on Adverse events of Anti-HIV Drugs) study, Professor Boyd and colleagues assessed the risks of cardiovascular disease and chronic kidney disease in people with HIV infection. They found elevated risks of each disease occurring simultaneously.

08 November 2017
EurekAlert (press release)
UK Reports Its First Kidney Transplants From HIV+ Donor to HIV+ Recipients

Kidneys from a deceased HIV-positive donor were successfully transplanted in two HIV-positive recipients, U.K. researchers report.

30 October 2017
Medscape (requires free registration)
Clinical Commissioning Policy: Tenofovir Alafenamide for treatment of HIV 1 in adults and adolescents

TAF containing products can be made available to patients who have defined renal or bone problems or who have medical reasons why they cannot take other HIV drugs.

06 March 2017
NHS England
HIV-positive kidney failure patients face greater hurdles in receiving necessary transplants

A new study finds that HIV-infected individuals with kidney failure are less likely to receive a kidney transplant — especially from living donors — than their uninfected counterparts.

24 February 2017
University of Alabama Birmingham press release
Ask A Pharmacist: With a new tenofovir, should you switch to Descovy, Genvoya or Odefsey?

I’ve heard more than a few patients ask, what should I do? If I’m already taking Complera, Stribild or Truvada, should I switch to the newer drug formulation with tenofovir alafenamide (TAF)?

20 September 2016
BETA blog
Not So Fast: Do people with HIV really experience accelerated aging?

Recent talk about HIV and aging has almost always been scary. A number of studies conclude that people living with HIV have so-called “accelerated aging”—meaning they will suffer heart attacks, strokes, cancers, and osteoporosis more often and sooner than those without HIV. Well, this is one article on aging and HIV that will challenge the concept of people living with HIV having an early expiration date. Instead, we can look at what we know and what we don’t, to get a better idea of what the risks are for HIV-positive people growing older—and what they can do about them.

08 July 2016
Positively Aware
← First12345...6Next →

Filter by country

Community Consensus Statement on Access to HIV Treatment and its Use for Prevention

Together, we can make it happen

We can end HIV soon if people have equal access to HIV drugs as treatment and as PrEP, and have free choice over whether to take them.

Launched today, the Community Consensus Statement is a basic set of principles aimed at making sure that happens.

The Community Consensus Statement is a joint initiative of AVAC, EATG, MSMGF, GNP+, HIV i-Base, the International HIV/AIDS Alliance, ITPC and NAM/aidsmap

This content was checked for accuracy at the time it was written. It may have been superseded by more recent developments. NAM recommends checking whether this is the most current information when making decisions that may affect your health.

NAM’s information is intended to support, rather than replace, consultation with a healthcare professional. Talk to your doctor or another member of your healthcare team for advice tailored to your situation.